TcLand Expression launches the "PRINT" international clinical trial to validate its blood biomarker RA-INF-Dx and announces the recruitment of its first patient

24-Feb-2011 - TcLand Expression SA announced the launch of the PRINT trial ("Predicting non-response to infliximab therapy") and the recruitment of its first patient in a French rheumatology center. PRINT is a prospective, international, multicenter trial seeking to validate the blood-based biomarker RA-INF-Dx ...

TcLand Expression appoints its Scientific and Medical Advisory Board dedicated to Rheumatology

17-Jan-2011 - TcLand Expression SA announced the appointment of key opinion leaders to its Scientific and Medical Advisory Board dedicated to Rheumatology. Chaired by Doctor Pierre Miossec, Professor of Clinical Immunology and Head of the Immunogenetics and Inflammation Department at the Edouard Herriot ...

TcLand Expression signs a licensing agreement with Inserm Transfert

Strategic collaboration on the development of companion diagnostic tests for rheumatoid arthritis therapies

08-Jul-2010 - TcLand Expression SA announced the signature of a licensing agreement with Inserm Transfert. The terms of the agreement include the grant of worldwide, exclusive licenses to TcLand Expression for two different patents covering gene expression signatures which can predict responsiveness to ...

TcLand Expression appoints personalized medicine pioneer Patrick Terry as Chairman of the Board of Directors

21-Jun-2010 - TcLand Expression SA announced the appointment of Patrick Terry as Chairman of the company's Board of Directors. Patrick Terry (a Board member since 2009) succeeds TcLand Expression CEO Alain Huriez MD, who had held the position since 2005. TcLand Expression is developing gene expression ...

TcLand Expression in compliance with the ISO 13485:2003 for its in vitro medical diagnostics

19-Apr-2010 - TcLand Expression announced that it had achieved ISO 13485:2003 compliance of its quality management system and renewal of its existing ISO 17025:2005 accreditation. One year after the company's ISO 17025:2005 accreditation for the performance of gene expression assays, TcLand Expression has ...